Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on Liquidia's (NASDAQ:LQDA) growing losses don't faze investors as the stock rallies 12% this past week - Yahoo

Liquidia's (NASDAQ:LQDA) growing losses don't faze investors as the stock rallies 12% this past week  Yahoo

Liquidia's (NASDAQ:LQDA) growing losses don't faze investors as the stock rallies 12% this past week - Yahoo

Click here to get full coverage on Liquidia Wins Court Battle and Lands $50M Funding After YUTREPIA's First Commercial Sale - Stock Titan

Liquidia Wins Court Battle and Lands $50M Funding After YUTREPIA's First Commercial Sale  Stock Titan

Liquidia Wins Court Battle and Lands $50M Funding After YUTREPIA's First Commercial Sale - Stock Titan

Click here to get full coverage on Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates  Nasdaq

Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

Click here to get full coverage on What Next For Liquidia After Launch? (NASDAQ:LQDA) - Seeking Alpha

What Next For Liquidia After Launch? (NASDAQ:LQDA)  Seeking Alpha

What Next For Liquidia After Launch? (NASDAQ:LQDA) - Seeking Alpha

Click here to get full coverage on Investors might be losing patience for Liquidia's (NASDAQ:LQDA) increasing losses, as stock sheds 20% over the past week - simplywall.st

Investors might be losing patience for Liquidia's (NASDAQ:LQDA) increasing losses, as stock sheds 20% over the past week  simplywall.st

Investors might be losing patience for Liquidia's (NASDAQ:LQDA) increasing losses, as stock sheds 20% over the past week - simplywall.st

Click here to get full coverage on Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result - Yahoo Finance

Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result  Yahoo Finance

Earnings To Watch: Liquidia Corp (LQDA) Reports Q1 2025 Result - Yahoo Finance

Click here to get full coverage on Liquidia Executive Team to Reveal Latest Business Developments at Major Healthcare Conference - Stock Titan

Liquidia Executive Team to Reveal Latest Business Developments at Major Healthcare Conference  Stock Titan

Liquidia Executive Team to Reveal Latest Business Developments at Major Healthcare Conference - Stock Titan

Click here to get full coverage on Liquidia: Competitor Insmed's Stunning PAH Data Arrives At Precisely The Wrong Time (LQDA) - Seeking Alpha

Liquidia: Competitor Insmed's Stunning PAH Data Arrives At Precisely The Wrong Time (LQDA)  Seeking Alpha

Liquidia: Competitor Insmed's Stunning PAH Data Arrives At Precisely The Wrong Time (LQDA) - Seeking Alpha

Click here to get full coverage on Analysts Are Updating Their Liquidia Corporation (NASDAQ:LQDA) Estimates After Its First-Quarter Results - simplywall.st

Analysts Are Updating Their Liquidia Corporation (NASDAQ:LQDA) Estimates After Its First-Quarter Results  simplywall.st

Analysts Are Updating Their Liquidia Corporation (NASDAQ:LQDA) Estimates After Its First-Quarter Results - simplywall.st

Click here to get full coverage on Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates  Yahoo Finance

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on LQDA gains USD 50m funding after court win, YUTREPIA launch | LQDA SEC Filing - Form 8-K - Stock Titan

LQDA gains USD 50m funding after court win, YUTREPIA launch | LQDA SEC Filing - Form 8-K  Stock Titan

LQDA gains USD 50m funding after court win, YUTREPIA launch | LQDA SEC Filing - Form 8-K - Stock Titan

Click here to get full coverage on When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - simplywall.st

When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable?  simplywall.st

When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - simplywall.st

Click here to get full coverage on Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month - Seeking Alpha

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month  Seeking Alpha

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month - Seeking Alpha

Click here to get full coverage on Buckley Capital’s Views on Liquidia Corp. (LQDA) - Yahoo Finance

Buckley Capital’s Views on Liquidia Corp. (LQDA)  Yahoo Finance

Buckley Capital’s Views on Liquidia Corp. (LQDA) - Yahoo Finance

Click here to get full coverage on Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics - Stock Titan

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics  Stock Titan

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics - Stock Titan

Click here to get full coverage on Rare Disease Biotech Liquidia Schedules Critical 2024 Financial Review - Stock Titan

Rare Disease Biotech Liquidia Schedules Critical 2024 Financial Review  Stock Titan

Rare Disease Biotech Liquidia Schedules Critical 2024 Financial Review - Stock Titan

Click here to get full coverage on Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... - Yahoo Finance

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...  Yahoo Finance

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... - Yahoo Finance

Click here to get full coverage on Liquidia Lands Massive $100M Funding Deal: YUTREPIA Commercial Launch Gets Major Boost - Stock Titan

Liquidia Lands Massive $100M Funding Deal: YUTREPIA Commercial Launch Gets Major Boost  Stock Titan

Liquidia Lands Massive $100M Funding Deal: YUTREPIA Commercial Launch Gets Major Boost - Stock Titan

Click here to get full coverage on Legal Victory: Liquidia Clears Major Hurdle for YUTREPIA Dual-Indication Approval This Month - Stock Titan

Legal Victory: Liquidia Clears Major Hurdle for YUTREPIA Dual-Indication Approval This Month  Stock Titan

Legal Victory: Liquidia Clears Major Hurdle for YUTREPIA Dual-Indication Approval This Month - Stock Titan

Click here to get full coverage on Newly FDA-Approved YUTREPIA Launches for PAH Treatment After Legal Victory Against United Therapeutics - Stock Titan

Newly FDA-Approved YUTREPIA Launches for PAH Treatment After Legal Victory Against United Therapeutics  Stock Titan

Newly FDA-Approved YUTREPIA Launches for PAH Treatment After Legal Victory Against United Therapeutics - Stock Titan

Click here to get full coverage on Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha

Liquidia Corp.: We Have Exposure To The Upside Now  Seeking Alpha

Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha

Click here to get full coverage on Notable Friday Option Activity: LQDA, SEPN, AM - Nasdaq

Notable Friday Option Activity: LQDA, SEPN, AM  Nasdaq

Notable Friday Option Activity: LQDA, SEPN, AM - Nasdaq

Click here to get full coverage on Breakthrough YUTREPIA Data: 3 New Studies Reveal Critical Patient Outcomes at ATS 2025 - Stock Titan

Breakthrough YUTREPIA Data: 3 New Studies Reveal Critical Patient Outcomes at ATS 2025  Stock Titan

Breakthrough YUTREPIA Data: 3 New Studies Reveal Critical Patient Outcomes at ATS 2025 - Stock Titan

Click here to get full coverage on Liquidia: United Therapeutics Has The Last Laugh (LQDA) - Seeking Alpha

Liquidia: United Therapeutics Has The Last Laugh (LQDA)  Seeking Alpha

Liquidia: United Therapeutics Has The Last Laugh (LQDA) - Seeking Alpha

Click here to get full coverage on Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update - Stock Titan

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update  Stock Titan

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update - Stock Titan

Click here to get full coverage on Bearish Sentiment Surrounds Liquidia (LQDA) with Elevated Put Ac - GuruFocus

Bearish Sentiment Surrounds Liquidia (LQDA) with Elevated Put Ac  GuruFocus

Bearish Sentiment Surrounds Liquidia (LQDA) with Elevated Put Ac - GuruFocus

Click here to get full coverage on Liquidia Secures $50 Million Funding Boost - TipRanks

Liquidia Secures $50 Million Funding Boost  TipRanks

Liquidia Secures $50 Million Funding Boost - TipRanks

Click here to get full coverage on Liquidia Technologies Signs Lease for New Facility - TipRanks

Liquidia Technologies Signs Lease for New Facility  TipRanks

Liquidia Technologies Signs Lease for New Facility - TipRanks

Click here to get full coverage on Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ... - Yahoo Finance

Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...  Yahoo Finance

Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ... - Yahoo Finance

Click here to get full coverage on Liquidia Executives to Reveal Latest Cardiopulmonary Disease Strategy at Major BofA Healthcare Conference - Stock Titan

Liquidia Executives to Reveal Latest Cardiopulmonary Disease Strategy at Major BofA Healthcare Conference  Stock Titan

Liquidia Executives to Reveal Latest Cardiopulmonary Disease Strategy at Major BofA Healthcare Conference - Stock Titan

Click here to get full coverage on Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha

Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA)  Seeking Alpha

Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha

Click here to get full coverage on BTIG Raises Liquidia Price Target Following YUTREPIA Approval - MSN

BTIG Raises Liquidia Price Target Following YUTREPIA Approval  MSN

BTIG Raises Liquidia Price Target Following YUTREPIA Approval - MSN

Click here to get full coverage on Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year - simplywall.st

Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year  simplywall.st

Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year - simplywall.st

Click here to get full coverage on Breakthrough FDA Approval: YUTREPIA's Novel Dry-Powder Tech Targets 105,000 PAH and PH-ILD Patients - Stock Titan

Breakthrough FDA Approval: YUTREPIA's Novel Dry-Powder Tech Targets 105,000 PAH and PH-ILD Patients  Stock Titan

Breakthrough FDA Approval: YUTREPIA's Novel Dry-Powder Tech Targets 105,000 PAH and PH-ILD Patients - Stock Titan

Click here to get full coverage on Liquidia (LQDA) Trading Resumes After Brief Halt | LQDA Stock Ne - GuruFocus

Liquidia (LQDA) Trading Resumes After Brief Halt | LQDA Stock Ne  GuruFocus

Liquidia (LQDA) Trading Resumes After Brief Halt | LQDA Stock Ne - GuruFocus

Click here to get full coverage on DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC Filing - Form 3 - Stock Titan

DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC Filing - Form 3  Stock Titan

DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC Filing - Form 3 - Stock Titan

Click here to get full coverage on DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC Filing - Form 4 - Stock Titan

DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC Filing - Form 4  Stock Titan

DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC Filing - Form 4 - Stock Titan

Click here to get full coverage on BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQ - GuruFocus

BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQ  GuruFocus

BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQ - GuruFocus

Click here to get full coverage on Noteworthy Monday Option Activity: LQDA, CENX, CRM - Nasdaq

Noteworthy Monday Option Activity: LQDA, CENX, CRM  Nasdaq

Noteworthy Monday Option Activity: LQDA, CENX, CRM - Nasdaq

Click here to get full coverage on Liquidia stock rises as Yutrepia undergoes FDA review (LQDA) - Seeking Alpha

Liquidia stock rises as Yutrepia undergoes FDA review (LQDA)  Seeking Alpha

Liquidia stock rises as Yutrepia undergoes FDA review (LQDA) - Seeking Alpha

Click here to get full coverage on LIQUIDIA TECHNOLOGIES Earnings Results: $LQDA Reports Quarterly Earnings - Quiver Quantitative

LIQUIDIA TECHNOLOGIES Earnings Results: $LQDA Reports Quarterly Earnings  Quiver Quantitative

LIQUIDIA TECHNOLOGIES Earnings Results: $LQDA Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Liquidia Drug Approved As Rival United Throws Hail Mary To Delay Actual Launch - Hunterbrook

Liquidia Drug Approved As Rival United Throws Hail Mary To Delay Actual Launch  Hunterbrook

Liquidia Drug Approved As Rival United Throws Hail Mary To Delay Actual Launch - Hunterbrook

Click here to get full coverage on Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA) - Yahoo Finance

Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA)  Yahoo Finance

Here’s Arquitos Capital Management’s Updates on Liquidia (LQDA) - Yahoo Finance

Click here to get full coverage on Trading Halted for Liquidia (LQDA) as Anticipated News Awaits | - GuruFocus

Trading Halted for Liquidia (LQDA) as Anticipated News Awaits |  GuruFocus

Trading Halted for Liquidia (LQDA) as Anticipated News Awaits | - GuruFocus

Click here to get full coverage on FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute - Insider Monkey

FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute  Insider Monkey

FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute - Insider Monkey

Click here to get full coverage on Analysts Have Just Cut Their Liquidia Corporation (NASDAQ:LQDA) Revenue Estimates By 11% - simplywall.st

Analysts Have Just Cut Their Liquidia Corporation (NASDAQ:LQDA) Revenue Estimates By 11%  simplywall.st

Analysts Have Just Cut Their Liquidia Corporation (NASDAQ:LQDA) Revenue Estimates By 11% - simplywall.st

Click here to get full coverage on How To Trade (LQDA) - news.stocktradersdaily.com

How To Trade (LQDA)  news.stocktradersdaily.com

How To Trade (LQDA) - news.stocktradersdaily.com

Click here to get full coverage on Liquidia Technologies Gains FDA Approval for YUTREPIA - TipRanks

Liquidia Technologies Gains FDA Approval for YUTREPIA  TipRanks

Liquidia Technologies Gains FDA Approval for YUTREPIA - TipRanks

Click here to get full coverage on Notable Thursday Option Activity: INSM, UNH, LQDA - Nasdaq

Notable Thursday Option Activity: INSM, UNH, LQDA  Nasdaq

Notable Thursday Option Activity: INSM, UNH, LQDA - Nasdaq

Click here to get full coverage on U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) - Yahoo Finance

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)  Yahoo Finance

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) - Yahoo Finance

Click here to get full coverage on (LQDA) Trading Advice - news.stocktradersdaily.com

(LQDA) Trading Advice  news.stocktradersdaily.com

(LQDA) Trading Advice - news.stocktradersdaily.com

Click here to get full coverage on Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ... - Yahoo Finance

Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...  Yahoo Finance

Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ... - Yahoo Finance

Click here to get full coverage on Rare Disease Pioneer Liquidia Takes Center Stage at Major Healthcare Conference - Stock Titan

Rare Disease Pioneer Liquidia Takes Center Stage at Major Healthcare Conference  Stock Titan

Rare Disease Pioneer Liquidia Takes Center Stage at Major Healthcare Conference - Stock Titan

Click here to get full coverage on (LQDA) Investment Analysis and Advice - news.stocktradersdaily.com

(LQDA) Investment Analysis and Advice  news.stocktradersdaily.com

(LQDA) Investment Analysis and Advice - news.stocktradersdaily.com

Click here to get full coverage on Liquidia Technologies Holds Annual Stockholders Meeting - TipRanks

Liquidia Technologies Holds Annual Stockholders Meeting  TipRanks

Liquidia Technologies Inc (LQDA)

Price Chart

Key Statistics

Technicals

About LQDA

Latest News

Liquidia's (NASDAQ:LQDA) growing losses don't faze investors as the stock rallies 12% this past week - Yahoo

Liquidia Wins Court Battle and Lands $50M Funding After YUTREPIA's First Commercial Sale - Stock Titan

Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

Advanced Charts

Top Gainers

Top Losers